Treatment of Childhood Lymphangiomas With Interferon-α

M. A. Reinhardt(Children’s Minnesota - St. Paul Hospital), Mark E. Nesbit(The Wistar Institute), Bruce Bostrom(Minnesota West Community & Technical College), Susan Sencer(University of Minnesota Children's Hospital), Stephen C. Kurachek(Children's Minnesota), Stephen C. Nelson(Children’s Minnesota - St. Paul Hospital)

Journal of Pediatric Hematology/Oncology

May 1, 1997

10.1097/00043426-199705000-00010

Cited by 76

Related Papers

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

|Cancer|1979|1.1k

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

|The Lancet|2015|518

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1987|334